Abstract |
The nucleophosmin (NPM1) activates cancer development and progression in many malignant tumors. However, the regulatory role and underlying mechanisms of NPM1 in pancreatic cancer are unknown. In this study, we showed that NPM1 was up-regulated in PDAC, which indicated a poor prognosis. We also identified NPM1 could stimulate aerobic glycolysis and repress fructose-1, 6-bisphosphatase 1 (FBP1) in pancreatic cancer cells. Restoring FBP1 expression partially reversed the tumor-promoting effects of NPM1, while the loss of FBP1 in PDAC tissues was indicative of a poorer prognosis. In sum, NPM1 promotes aerobic glycolysis and tumor progression in patients with pancreatic cancer by inhibiting FBP1.
|
Authors | Yi Zhu, Minmin Shi, Hao Chen, Jiangning Gu, Jiaqiang Zhang, Baiyong Shen, Xiaxing Deng, Junjie Xie, Xi Zhan, Chenghong Peng |
Journal | Oncotarget
(Oncotarget)
Vol. 6
Issue 25
Pg. 21443-51
(Aug 28 2015)
ISSN: 1949-2553 [Electronic] United States |
PMID | 26068981
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- DNA-Binding Proteins
- FUBP1 protein, human
- Lactates
- NPM1 protein, human
- Npm1 protein, mouse
- Nuclear Proteins
- RNA-Binding Proteins
- Nucleophosmin
- DNA Helicases
- Glucose
|
Topics |
- Animals
- Biomarkers, Tumor
(metabolism)
- Carcinoma, Pancreatic Ductal
(metabolism, pathology)
- Cell Line, Tumor
- DNA Helicases
(antagonists & inhibitors, metabolism)
- DNA-Binding Proteins
(antagonists & inhibitors, metabolism)
- Disease Progression
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Glucose
(chemistry)
- Glycolysis
- HEK293 Cells
- Humans
- Immunohistochemistry
- Lactates
(chemistry)
- Male
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Nuclear Proteins
(metabolism)
- Nucleophosmin
- Pancreatic Neoplasms
(metabolism, pathology)
- Prognosis
- RNA-Binding Proteins
- Tissue Array Analysis
- Up-Regulation
|